A Direct-to-Patient Platform Built for Biopharma

ixlayer’s unified direct-to-patient platform, helps biopharma transform the patient experience

Simplify and Accelerate the Connection to Care

42%

Scheduled a visit with a
physician after receiving
abnormal lab results.

+2.5x

Patient activation increase
vs. traditional outreach.

+70%

Increase in diagnostic testing compliance vs. U.S benchmark.

The Value of a
Direct-to-Patient Platform

Intuitive interface and simple one-time sign-on supports continuous patient engagement

Connection to PCPs and Specialists virtually and in-person accelerates the connection to care

Deep partnerships across the healthcare ecosystem support multiple, differentiated patient journeys

Proactive care and convenient health access drive earlier interventions and help patients achieve their health goals

How We Support Patients

ixlayer connects a vast health ecosystem for a convenient and seamless virtual patient experience. Users can screen for health conditions, easily monitor their health, seamlessly connect with care providers and have medication delivered all without leaving our platform.

Supporting Commercial Innovation &
Brand Marketing Needs

Drive Success with a Unified Patient Journey

Seamlessly integrate with a vast health ecosystem and launch services to support specific brand initiatives.

Our Platform

Built on a secure technological backbone, our flexible product design enables rapid deployment and scalability, and allows us to configure solutions to best meet our clients’ needs across multiple therapeutic areas.

Our Services

Telehealth services, lab testing, Rx fulfillment, benefits verification, and more can be implemented across a patient journey designed to support different patient needs and priorities.

Improving the Healthcare Experience for All

We offer our clients the opportunity to deliver a personalized healthcare journey to all patients with our fully integrated, configurable platform. We have powered over 1,100 nationwide programs and enabled over 4 million patient care journeys for greater operational efficiency, patient access, and improved outcomes.

What Our Clients Have to Say

Across the biopharma industry,
our clients value our speed, our service and our solutions.

Industry Insights

The latest research, news and expert opinion keeping you up to date on DTP industry innovation.

Video

Fierce Pharma interview

Fierce Pharma publisher Rebecca Willumson caught up with ixlayer’s General Manager of Biopharma, Matthew Walsh, at Digital Pharma East 2024

More